These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15486605)

  • 1. Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders.
    Berry MD
    J Psychiatry Neurosci; 2004 Sep; 29(5):337-45. PubMed ID: 15486605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
    Gerszon J; Rodacka A
    Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs.
    Ishitani R; Tajima H; Takata H; Tsuchiya K; Kuwae T; Yamada M; Takahashi H; Tatton NA; Katsube N
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):291-301. PubMed ID: 12657368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders?
    Mazzola JL; Sirover MA
    Neurotoxicology; 2002 Oct; 23(4-5):603-9. PubMed ID: 12428732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology.
    Sirover MA
    J Cell Biochem; 1997 Aug; 66(2):133-40. PubMed ID: 9213215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases.
    Chuang DM; Hough C; Senatorov VV
    Annu Rev Pharmacol Toxicol; 2005; 45():269-90. PubMed ID: 15822178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase upon serum depletion.
    Schmitz HD
    Eur J Cell Biol; 2001 Jun; 80(6):419-27. PubMed ID: 11484933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease.
    El Kadmiri N; Slassi I; El Moutawakil B; Nadifi S; Tadevosyan A; Hachem A; Soukri A
    Pathol Biol (Paris); 2014 Dec; 62(6):333-6. PubMed ID: 25246025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts.
    Mazzola JL; Sirover MA
    J Neurochem; 2001 Jan; 76(2):442-9. PubMed ID: 11208907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase.
    Ismail SA; Park HW
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1508-13. PubMed ID: 16239728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyceraldehyde-3-phosphate dehydrogenase and apoptosis.
    Berry MD; Boulton AA
    J Neurosci Res; 2000 Apr; 60(2):150-4. PubMed ID: 10740219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer.
    Carlile GW; Chalmers-Redman RM; Tatton NA; Pong A; Borden KE; Tatton WG
    Mol Pharmacol; 2000 Jan; 57(1):2-12. PubMed ID: 10617673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyceraldehyde-3-phosphate dehydrogenase aggregation inhibitor peptide: A potential therapeutic strategy against oxidative stress-induced cell death.
    Itakura M; Nakajima H; Semi Y; Higashida S; Azuma YT; Takeuchi T
    Biochem Biophys Res Commun; 2015 Nov; 467(2):373-6. PubMed ID: 26431872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite.
    Souza JM; Radi R
    Arch Biochem Biophys; 1998 Dec; 360(2):187-94. PubMed ID: 9851830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases.
    Waldmeier P; Bozyczko-Coyne D; Williams M; Vaught JL
    Biochem Pharmacol; 2006 Nov; 72(10):1197-206. PubMed ID: 16901468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis.
    Tsuchiya K; Tajima H; Yamada M; Takahashi H; Kuwae T; Sunaga K; Katsube N; Ishitani R
    Life Sci; 2004 May; 74(26):3245-58. PubMed ID: 15094325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol.
    Gregus Z; Németi B
    Toxicol Sci; 2005 Jun; 85(2):859-69. PubMed ID: 15788719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
    Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM
    Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glyceraldehyde-3-phosphate dehydrogenase activity by antibodies present in the cerebrospinal fluid of patients with multiple sclerosis.
    Kölln J; Zhang Y; Thai G; Demetriou M; Hermanowicz N; Duquette P; van den Noort S; Qin Y
    J Immunol; 2010 Aug; 185(3):1968-75. PubMed ID: 20610654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Properties and functional diversity of glyceraldehyde-3-phosphate dehydrogenase].
    Rodacka A
    Postepy Hig Med Dosw (Online); 2013 Aug; 67():775-89. PubMed ID: 24018444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.